Deep Brain Stimulation
Africa · 1 shared keyword
Updated
Reviewed by Vidhi Upadhyay
Africa Spinal Cord Stimulation Market Industry Trends and Forecast to 2034: Segmented by (Product, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$74.1 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $53.5 Mn | — | — |
| 2025 (base) | $58.6 Mn | +$5.1 Mn | — |
| 2026 (forecast) | $64.2 Mn | +$5.6 Mn | +9.5% |
| 2027 (forecast) | $70.3 Mn | +$6.1 Mn | +19.9% |
| 2028 (forecast) | $77.0 Mn | +$6.7 Mn | +31.3% |
| 2029 (forecast) | $84.3 Mn | +$7.3 Mn | +43.8% |
| 2030 (forecast) | $92.3 Mn | +$8.0 Mn | +57.4% |
| 2031 (forecast) | $101.1 Mn | +$8.8 Mn | +72.4% |
| 2032 (forecast) | $110.7 Mn | +$9.6 Mn | +88.8% |
| 2033 (forecast) | $121.2 Mn | +$10.5 Mn | +106.7% |
| 2034 (forecast) | $132.7 Mn | +$11.5 Mn | +126.3% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $58.6 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $132.7 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 9.5% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, indication and end user (see all) |
| Key players | Medtronic, Boston Scientific Corporation, Abbott Laboratories, Nevro, Saluda Medical (see all) |
| Regulator in Africa | AMASource: African Union, African Medicines Agency treaty. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Spinal cord stimulation sends mild electrical pulses to the spinal cord to block chronic pain signals.
Key segments of the spinal Cord Stimulation market include product (Rechargeable, Non-Rechargeable and Closed-Loop) and indication (Failed Back Surgery, Diabetic Neuropathy and Complex Regional Pain).
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the spinal Cord Stimulation market.
Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the spinal Cord Stimulation market strong room to grow.
Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the spinal Cord Stimulation market.
The spinal Cord Stimulation market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products.[1] In some of the countries we cover here, medical devices are regulated by EDA (Egypt)[2], PPB (Kenya)[3] and SAHPRA (South Africa)[4]. How care is paid for in some of these countries: universal health insurance (Egypt)[5], the SHA (Kenya)[6] and planned National Health Insurance (South Africa)[7].
[1] African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
[2] Egyptian Drug Authority. Checked 14 Nov 2026.
[3] Pharmacy and Poisons Board. Checked 14 Nov 2026.
[4] South African Health Products Regulatory Authority. Checked 14 Nov 2026.
[5] Universal Health Insurance Authority. Checked 14 Nov 2026.
[6] Social Health Authority. Checked 14 Nov 2026.
[7] National Department of Health. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how spinal Cord Stimulation products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Africa.
What doctors and scientists are doing in Spinal Cord Stimulation right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Africa · 1 shared keyword
Africa
Africa
Africa
Africa
Africa
Pharmaceuticals · Africa
Pharmaceuticals · Africa
Pharmaceuticals · Africa
Healthcare Services · Africa
Pharmaceuticals · Africa
Pharmaceuticals · Africa